Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Beltrame

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
International Journal of Cancer|February 26, 2020
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancerGiuseppe Benvenuto, Paola Todeschini, Lara Paracchini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2016
lncRNAs as Novel Indicators of Patients' Prognosis in Stage I Epithelial Ovarian Cancer: A Retrospective and Multicentric StudyPaolo Martini, Lara Paracchini, Giulia Caratti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2013
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificitiesEnrica Calura, Robert Fruscio, Lara Paracchini, et al.
Cancer Cell|February 16, 2013
Role of macrophage targeting in the antitumor activity of trabectedinGiovanni Germano, Roberta Frapolli, Cristina Belgiovine, et al.
Oncotarget|October 6, 2017
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory proteinSonja I Buschow, Matteo Ramazzotti, Inge M J Reinieren-Beeren, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 10, 2017
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patientsRenata A Tassi, Paola Todeschini, Eric R Siegel, et al.
Immunome Research|November 25, 2010
DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cellsDuccio Cavalieri, Damariz Rivero, Luca Beltrame, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
International Journal of Cancer|February 26, 2020
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancerGiuseppe Benvenuto, Paola Todeschini, Lara Paracchini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2016
lncRNAs as Novel Indicators of Patients' Prognosis in Stage I Epithelial Ovarian Cancer: A Retrospective and Multicentric StudyPaolo Martini, Lara Paracchini, Giulia Caratti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2013
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificitiesEnrica Calura, Robert Fruscio, Lara Paracchini, et al.
Cancer Cell|February 16, 2013
Role of macrophage targeting in the antitumor activity of trabectedinGiovanni Germano, Roberta Frapolli, Cristina Belgiovine, et al.
Oncotarget|October 6, 2017
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory proteinSonja I Buschow, Matteo Ramazzotti, Inge M J Reinieren-Beeren, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 10, 2017
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patientsRenata A Tassi, Paola Todeschini, Eric R Siegel, et al.
Immunome Research|November 25, 2010
DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cellsDuccio Cavalieri, Damariz Rivero, Luca Beltrame, et al.
Pageof 6